Yusuke Furukawa

Researcher Name Resolver ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Venues

Leukemia

PloS one

Cancer science

Clinical cancer research : an official journal of the American Association for Cancer Research

Jichi Medical University

University of Tsukuba (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Jichi Medical University Apr 01 2014

Japan

Director :: Center for Molecular Medicine

Jichi Medical University Aug 01 2003

Japan

Professor of Medicine :: Division of Stem Cell Regulation

Jichi Medical University Sep 01 1999 - Jul 31 2003

Japan

Associate Professor :: Division of Stem Cell Regulation

Jichi Medical University Sep 01 1992 - Aug 31 1999

Japan

Assistant Professor :: Division of Hemopoiesis

Jichi Medical University Oct 01 1990 - Aug 31 1992

Japan

Instructor in Medicine :: Division of Hemopoiesis

Dana Farber Cancer Institute Sep 07 1988 - Sep 30 1990

United States

Research Fellow :: Department of Medicine

Harvard Medical School Sep 07 1988 - Sep 30 1990

United States

Research Fellow :: Faculty of Medicine

Jichi Medical University Jan 01 1988 - Sep 06 1988

Japan

Instrutor in Medicine :: Division of Hemopoiesis

Jichi Medical University Hospital Jun 01 1987 - Dec 31 1987

Japan

Research Assistant :: Department of Hematology

Jichi Medical University Hospital Jun 01 1984 - May 31 1987

Japan

Senior Resident :: Department of Hematology

Jichi Medical University Hospital May 24 1982 - May 31 1984

Japan

Junior Resident :: Department of Internal Medicine

Education History

University of Tsukuba Apr 01 1976 - Mar 31 1978

Japan

BSC :: Faculty of Medicine

Publications

Naoki Osada, Jiro Kikuchi, Hidekatsu Iha, Hiroshi Yasui, Sho Ikeda, Naoto Takahashi, Yusuke Furukawa
c-FOS is an integral component of the IKZF1 transactivator complex and mediates lenalidomide resistance in multiple myeloma. Clinical and translational medicine 13 (8) (2023)
Jiro Kikuchi, Nobuyuki Kodama, Masataka Takeshita, Sho Ikeda, Takahiro Kobayashi, Yoshiaki Kuroda, Michihiro Uchiyama, Naoki Osada, Bjarne Bogen, Hiroshi Yasui, Naoto Takahashi, Akiyoshi Miwa, Yusuke Furukawa
EMD originates from hyaluronan-induced homophilic interactions of CD44 variant-expressing MM cells under shear stress. Blood advances (2022)
Naoki Yamamoto, Jiro Kikuchi, Yusuke Furukawa, Naoya Shibayama
Fast in-vitro screening of FLT3-ITD inhibitors using silkworm-baculovirus protein expression system. PloS one 17 (5) (2022)
Daisuke Koyama, Jiro Kikuchi, Yoshiaki Kuroda, Masatsugu Ohta, Yusuke Furukawa
AMP-activated protein kinase activation primes cytoplasmic translocation and autophagic degradation of the BCR-ABL protein in CML cells. Cancer science 112 (1) (2020)
Yusuke Furukawa, Jiro Kikuchi
Molecular basis of clonal evolution in multiple myeloma. International journal of hematology 111 (4) (2020)
Atsushi Suzuki, Satoshi Kakugawa, Masafumi Miyoshi, Mitsuo Hori, Kenshi Suzuki, Yusuke Furukawa, Kensuke Ohta
Soluble SLAMF7 is a predictive biomarker for elotuzumab therapy. Leukemia 34 (11) (2020)
Yoshiaki Kuroda, Akiko Yashima-Abo, Daisuke Koyama, Jiro Kikuchi, Shigehisa Mori, Shigeki Ito, Yusuke Furukawa
Bone marrow stromal cell-mediated degradation of CD20 leads to primary rituximab resistance in mantle cell lymphoma. Leukemia 35 (5) (2020)
Jiro Kikuchi, Mitsuo Hori, Hidekatsu Iha, Noriko Toyama-Sorimachi, Shotaro Hagiwara, Yoshiaki Kuroda, Daisuke Koyama, Tohru Izumi, Hiroshi Yasui, Atsushi Suzuki, Yusuke Furukawa
Soluble SLAMF7 promotes the growth of myeloma cells via homophilic interaction with surface SLAMF7. Leukemia 34 (1) (2019)
Shiori Saito, Jiro Kikuchi, Daisuke Koyama, Shin Sato, Naoki Osada, Yoshiaki Kuroda, Koshi Akahane, Takeshi Inukai, Takashi Umehara, Yusuke Furukawa
Eradication of Central Nervous System Leukemia of T-Cell Origin with a Brain-Permeable LSD1 Inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (5) (2018)

Yusuke Furukawa.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yusuke Furukawa